Effectiveness of eptinezumab unaffected by psychiatric comorbidities in chronic migraine
DENVER — For those experiencing chronic migraine, the presence of self-reported psychiatric conditions did not affect the effectiveness of eptinezumab, according to a poster at the American Academy of Neurology annual meeting.“It may be of value to understand better if a particular migraine treatment is likely to help somebody with migraine who has a psychiatric comorbidity compared